Mihael H. Polymeropoulos
2014
In 2014, Mihael H. Polymeropoulos earned a total compensation of $2.7M as President and Chief Executive Officer at Vanda Pharmaceuticals, a 7% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $435,000 |
|---|---|
| Option Awards | $1,053,000 |
| Salary | $580,000 |
| Stock Awards | $613,500 |
| Other | $18,799 |
| Total | $2,700,299 |
Polymeropoulos received $1.1M in option awards, accounting for 39% of the total pay in 2014.
Polymeropoulos also received $435K in non-equity incentive plan, $580K in salary, $613.5K in stock awards and $18.8K in other compensation.
Rankings
In 2014, Mihael H. Polymeropoulos' compensation ranked 3,361st out of 13,032 executives tracked by ExecPay. In other words, Polymeropoulos earned more than 74.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,361 out of 13,032 | 74th |
Division Manufacturing | 1,184 out of 4,966 | 76th |
Major group Chemicals And Allied Products | 383 out of 1,686 | 77th |
Industry group Drugs | 298 out of 1,365 | 78th |
Industry Pharmaceutical Preparations | 242 out of 1,043 | 77th |
Source: SEC filing on April 27, 2017.
Polymeropoulos' colleagues
We found two more compensation records of executives who worked with Mihael H. Polymeropoulos at Vanda Pharmaceuticals in 2014.